Source link : https://www.newshealth.biz/health-news/leukemia-drug-shows-promise-in-dementia-with-lewy-bodies/
The chronic myeloid leukemia drug nilotinib (Tasigna) improved biomarkers and cognitive outcomes in people with dementia with Lewy bodies (DLB), a small phase II trial showed. In a study of 43 DLB patients, nilotinib improved cognition scores by 2.8 points versus placebo (P=0.037) on the Alzheimer’s Disease Assessment Scale-Cognitive Subscale 14 (ADAS-Cog14) at 3 months, […]
Author : News Health
Publish date : 2024-10-30 21:16:34
Copyright for syndicated content belongs to the linked Source.
